Jeff Conn

Vanderbilt IP licensed to IPO-prospect Neumora might earn VU millions

Aug 26, 2023 at 12:14 pm by miltcapps

Update: Neumora's IPO went effective March 26, 2025 (NasdaqGS:NMRA). A PRELIMINARY IPO filing yesterday by Massachusetts-based Neumora Therapeutics lists among company advanta.... Read More

Appello Pharma completes Series A to advance treatment of Parkinson's

Dec 01, 2020 at 05:15 pm by miltcapps

Updated: Jan. 24, 2022: Appello filed for completion of a $13.5MM Series B equity raise.-Ed. NASHVILLE-BASED Appello Pharmaceuticals Inc. yesterday reported completing its Ser.... Read More

Venture Notes - September 26, 2018

Sep 26, 2018 at 08:45 am by miltcapps

Today: NueCura$ | TrackRef$ | Preteckt$ | IMAC$ | Joshi$ | Innova$ | Frist$ | Sports$ | Hepten$ | AgGenetics$ | AdvFin$ | Johnson | SBIR$ | SSM$ | Graphene | Auto | Galante |.... Read More

Drug-discovery linchpin PMI BioPharma Solutions hoists flag in Tennessee

Sep 19, 2018 at 05:00 pm by miltcapps

CHARTERED less than a year ago, PMI BioPharma Solutions LLC of Nashville and Celina, Tenn., is a privately held contract development and manufacturing organization (CDMO) that.... Read More

This week's LifeScienceTN program lineup is likely to spark venture ideas

Nov 13, 2012 at 09:10 am by miltcapps

LIFESCIENCE Tennessee's annual meeting in Nashville brings venture pitches, innovation imperatives and a deeper dive into many things Bio. Some VNC readers will call that with.... Read More

LifeScienceTN: Drug discovery gets spotlight in venture-oriented event

Nov 13, 2012 at 08:36 am by miltcapps

AN INCONSPICUOUS, but science-heavy panel discussion here this week may help eventually broaden Nashville's Bio-reputation. At the Vanderbilt Marriott this Thursday, Jeff Con.... Read More

NewsBits, March 21, 2011

Mar 21, 2011 at 08:35 am by miltcapps

Rep. Shipley Clean energy 'technology grab for Tennessee': Some State lawmakers are pushing for TNInvestco and State ECD support for two pilot plants that would gene.... Read More

VUMC scientists seek partners for neuro-drug discovery

Mar 21, 2011 at 08:07 am by miltcapps

Vanderbilt University Medical Center scientists, allied institutions and industry partners may be stepping-up their assault on pharmaceutical business-as-usual via VU's n.... Read More

Newsbits, Feb. 24, 2010

Feb 24, 2010 at 03:10 pm by miltcapps

TriStar Technology Fund, a TNInvestco certified company in Nashville, will have a strong presence during a major tech commercialization conference. As previously reported, th.... Read More

BioMimetic CEO urges 'build on Bredesen's start', plus greater Vanderbilt role in life-sciences ventures

Feb 24, 2010 at 01:23 pm by miltcapps

BioMimetic Therapeutics CEO Sam Lynch said development of the life-sciences industry in Nashville demands a greater role by Vanderbilt University and the focusing of the regio.... Read More

VNC Terms of Use

Jan 02, 2010 at 04:52 pm by miltcapps

Copyright 2010 Milt Capps CommunicationsVentureNashville.com, Venture Nashville Connections, VentureNashville on Blogger and other media are property of Milt Capps Communicati.... Read More

VU's Conn advocates new models for drug discovery

Dec 22, 2009 at 01:15 pm by miltcapps

A crisis of innovation grips "the entire biomedical research enterprise," according to the leader of the Vanderbilt Program in Drug Discovery. VPDD Director Jeff Conn, Ph.D.,.... Read More

Get the Newsletter